Antianginal effects of FR144420, a novel slow nitric oxide-releasing agent
| Autor: | Yasuko Kato, Shigetaka Nishino, Mitsuko Ohno, Jiro Seki, Yasuhiro Kita, Kazuhiro Maeda, Shinichi Fukuyama, Masayuki Kato, Hiroyuki Takamatu, Toshiko Sugimoto, Yoshimi Hirasawa |
|---|---|
| Rok vydání: | 1996 |
| Předmět: |
Male
Vasopressins Vasodilator Agents Coronary Vasospasm Blood Pressure Pharmacology Nitric Oxide Nitric oxide Rats Sprague-Dawley Electrocardiography chemistry.chemical_compound Oral administration medicine Animals ST segment Methacholine Chloride ST depression medicine.diagnostic_test business.industry ST elevation Nicotinic Acids Vasospasm Nitro Compounds medicine.disease Rats chemistry Anesthesia Coronary vasospasm medicine.symptom business |
| Zdroj: | European Journal of Pharmacology. 303:55-59 |
| ISSN: | 0014-2999 |
| DOI: | 10.1016/0014-2999(96)00105-7 |
| Popis: | The aim of this study was to compare the antianginal effects of two compounds that release nitric oxide (NO) spontaneously, i.e. (+/-)-N-[(E)-4-ethyl-3-[(Z-hydroxyimino]-5-nitro-3-hexenyl] -3-pyridinecarboxamide (FR144420) and (+/-)-(E)-ethyl-2-[(E)-hydroxyimino] -5-nitro-3-hexenamide (FK409), in two different rat models of coronary vasospasm. In the rat methacholine-induced coronary vasospasm model, FR144420 suppressed the elevation of the ST segment dose dependently and significantly at 1.0 mg/kg, i.d. 185 min after its administration. FK409 suppressed the ST elevation only 5 min after its administration at 1.0 mg/kg, i.d. FR144420 and FK409 significantly decreased mean blood pressure at all doses tested only 5 min after their intraduodenal administration, but did not change heart rate at any time. Although the suppression of the ST elevation by FK409 had the same duration as its hypotensive effect, the FR144420-induced suppression of the ST elevation lasted longer than its hypotensive effect. In the rat vasopressin-induced coronary vasospasm model, FR144420 (32 mg/kg) significantly inhibited the depression of the ST segment both 60 min and 120 min after oral administration, whereas FK409 (32 mg/kg) significantly inhibited this ST depression only 60 min after oral administration. These data suggest that FR144420 inhibits coronary vasospasm for longer than FK409 does and particularly shows more prolonged antianginal effects than hypotensive effects in the methacholine-induced coronary vasospasm model. Thus FR144420 is expected to be a useful NO releaser for investigating the in vivo actions of NO. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect